全文获取类型
收费全文 | 121871篇 |
免费 | 9227篇 |
国内免费 | 3050篇 |
专业分类
耳鼻咽喉 | 1244篇 |
儿科学 | 7198篇 |
妇产科学 | 3802篇 |
基础医学 | 13676篇 |
口腔科学 | 1569篇 |
临床医学 | 13205篇 |
内科学 | 20983篇 |
皮肤病学 | 2369篇 |
神经病学 | 10506篇 |
特种医学 | 2720篇 |
外国民族医学 | 3篇 |
外科学 | 11112篇 |
综合类 | 17147篇 |
现状与发展 | 15篇 |
预防医学 | 7328篇 |
眼科学 | 2235篇 |
药学 | 6159篇 |
54篇 | |
中国医学 | 11018篇 |
肿瘤学 | 1805篇 |
出版年
2024年 | 359篇 |
2023年 | 2167篇 |
2022年 | 4479篇 |
2021年 | 5897篇 |
2020年 | 5415篇 |
2019年 | 4251篇 |
2018年 | 4301篇 |
2017年 | 4407篇 |
2016年 | 4518篇 |
2015年 | 4302篇 |
2014年 | 8379篇 |
2013年 | 8658篇 |
2012年 | 6816篇 |
2011年 | 7946篇 |
2010年 | 6154篇 |
2009年 | 5962篇 |
2008年 | 5802篇 |
2007年 | 5913篇 |
2006年 | 5338篇 |
2005年 | 4416篇 |
2004年 | 3762篇 |
2003年 | 3332篇 |
2002年 | 2295篇 |
2001年 | 2085篇 |
2000年 | 1803篇 |
1999年 | 1681篇 |
1998年 | 1383篇 |
1997年 | 1293篇 |
1996年 | 1241篇 |
1995年 | 1205篇 |
1994年 | 1022篇 |
1993年 | 915篇 |
1992年 | 828篇 |
1991年 | 642篇 |
1990年 | 593篇 |
1989年 | 495篇 |
1988年 | 495篇 |
1987年 | 443篇 |
1986年 | 387篇 |
1985年 | 504篇 |
1984年 | 415篇 |
1983年 | 258篇 |
1982年 | 339篇 |
1981年 | 305篇 |
1980年 | 248篇 |
1979年 | 205篇 |
1978年 | 128篇 |
1977年 | 101篇 |
1976年 | 85篇 |
1975年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
101.
产科危重患者多器官功能障碍综合征的临床分析 总被引:4,自引:0,他引:4
目的 :分析产科危重患者多器官功能障碍综合征 (MODS)的发病特点及诱因 ,以及与急性生理与慢性健康状况评分II(APACHEII)的关系。方法 :回顾分析 2 0 0 0年1月至 2 0 0 4年 4月转入GICU产科危重患者中发生MODS 6 6例的临床资料 ,并计算其A PACHEII评分。结果 :产科MODS患者诱因主要是产科因素 ,共 4 8例 (72 .73% ) ,死亡 7例 (14 .5 8% ) ,以重度子痫前期或子痫及产后出血为主 ;诱因 18例妊娠合并内外科疾病 ,死亡 11例 ,死亡率为 6 1.11% ,以妊娠合并心脏病和妊娠合并重症肝炎为主。产科MODS患者死亡率随着器官损害数的增多而上升 ,差异有显著性 (P <0 .0 5 ) ;随着器官损害数的增多 ,APACHEII评分逐渐升高 ,差异有显著性 (P <0 .0 5 ) ;APACHEII评分用于预测MODS死亡阳性率 ,2 ,3,4 ,5个器官受损害 ,其阳性率分别为 33.4 5 % ,5 7.12 % ,97.0 9% ,10 0 %。结论 :产科多器官功能障碍 /衰竭的产科主要诱因是重度子痫前期 /子痫 ,产后出血 ;产科MODS患者死亡率也随着器官损害数的增多而上升 ;APACHEII评分可在一定程度上作为评定产科MODS患者病情危重程度和预测预后的指标。 相似文献
102.
103.
目的 探讨血管紧张素Ⅱ(AngⅡ)1型受体拮抗剂(ARB)洛沙坦对代谢综合征(MS)肾组织环氧化酶2(COX-2)表达的影响及其机制。 方法 把7周大的MS模型肥胖Zucker大鼠随机分成洛沙坦处理组和未处理组,以瘦Zucker大鼠为对照组,连续给药4个月后观察肾组织内COX-2的表达。另外,用AngⅡ刺激6 h的系膜细胞和用从微型渗透泵灌注AngⅡ 5 d的C57BL/6小鼠肾脏提取的肾皮质,观察COX-2的表达。采用RT-PCR和Western印迹法分别检测COX-2 mRNA和蛋白的表达。 结果 洛沙坦可阻止肥胖Zucker大鼠肾组织内COX-2表达增加。AngⅡ直接刺激可以诱导系膜细胞和肾组织内COX-2表达增加。 结论 AngⅡ可以调控MS肾组织内COX-2表达增加。ARB可以通过抑制COX-2的表达保护MS肾脏,这对应用非COX-2抑制剂来保护MS肾脏具有重要的意义。 相似文献
104.
105.
良性前列腺增生中医证型与尿动力学参数相关性研究 总被引:1,自引:0,他引:1
目的:探讨良性前列腺增生(BPH)中医证型与尿动力学参数的相关性。方法:152例BPH患者,中医辨证分为肾阴不足、肾阳虚弱、瘀阻水道、脾气虚弱、肺热气郁、湿热下注、痰浊郁结七型,均进行尿动力学检查。结果:152例BPH患者中,肾阳虚弱型71例(46.71%),瘀阻水道型40例(26.31%),肾阴不足型14例(9.21%)。膀胱出口梗阻为III~VI度肾阳虚弱型有58例,瘀阻水道型有38例,其中严重梗阻(V~VI)26例。膀胱逼尿肌收缩功能极弱中(n=12),肾阳虚弱型4例,占33.33%(4/12),瘀阻水道型7例,占58.33%(7/12);膀胱逼尿肌收缩功能弱者中(n=48),肾阳虚弱型为27例,占56.25%(27/48),瘀阻水道型17例,占35.42%(17/48)。结论:BPH中医各辨证分型与膀胱出口梗阻和膀胱逼尿肌收缩力有一定的相关性,从而为中医证型的量化和客观化提供相应的证据。 相似文献
106.
T Kato M Itoh J Hanashita T Itoi T Matsumoto Y Ono S Imamura N Hayakawa A Suzuki Y Mizutani Y Uchigata N Oda 《Diabetic medicine》2007,24(11):1279-1281
AIMS: A rare case of the insulin autoimmune syndrome (IAS) accompanied by insulin receptor anomaly is reported. METHODS: Antibodies to insulin and insulin receptor were determined in the patient with severe hypoglycaemia before and after the treatment with prednisolone. RESULTS: Titers of antibody to insulin and insulin receptors were 73.0% and 41.5%, respectively. Drug-induced lymphocyte stimulation tests were all negative for the suspicious drugs. Her HLA-DR was DRB1*0403/04051. Following steroid therapy, the formation of antibodies was suppressed and alleviated her symptoms. Scatchard analysis yielded findings specific to polyclonal antibodies. CONCLUSIONS: The changes in autoantibodies resulted in alleviation of the hypoglycemic symptoms as a result of steroid therapy. 相似文献
107.
B Gerdts AFPM Vloemans RW Kreis 《Journal of the European Academy of Dermatology and Venereology》2007,21(6):781-788
BACKGROUND: Toxic epidermal necrolysis (TEN) is a severe and potentially fatal drug reaction characterized by an extensive skin rash with blisters and exfoliation, frequently accompanied by mucositis. The wounds caused by TEN are similar to second-degree burns and severe cases may involve large areas of skin loss. OBJECTIVES: Analysis of our results in patients with TEN and evaluation of the variety of therapeutic interventions that has been studied and suggested in TEN. PATIENTS/METHODS: Retrospective analysis of 19 consecutive patients with TEN treated in our burns centre between 1989 and 2004. RESULTS: Immediate withdrawal of any potentially fatal drug, maximum supportive care, and a restricted and tailored antibiotic, medical and surgical treatment regimen confined mortality to 21%, whereas prognosis scores like APACHE II and SCORTEN predicted mortality of 22 and 30%, respectively. A positive contribution of selective digestive decontamination is suggested but has yet to be established. CONCLUSIONS: Because of a potentially fatal outcome, fast referral of a patient suspected of TEN to a specialized centre (mostly a burns unit or specialized dermatology centre) for expert wound management and tailored comprehensive care is strongly advised and contributes to survival. 相似文献
108.
Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. 总被引:5,自引:0,他引:5
G Targher 《Diabetic medicine》2007,24(1):1-6
Non-alcoholic fatty liver disease (NAFLD) affects a substantial proportion of the general population and is frequently associated with many features of the metabolic syndrome (MetS). Currently, the importance of NAFLD and its relationship with the MetS is being increasingly recognized, and this has stimulated an interest in the possible role of NAFLD in the development of atherosclerosis. Recent studies have reported the association of NAFLD with multiple classical and non-classical risk factors for cardiovascular disease (CVD). Moreover, there is a strong association between the severity of liver histopathology in NAFLD patients and greater carotid artery intima-media thickness and plaque, and lower endothelial flow-mediated vasodilation (as markers of subclinical atherosclerosis) independent of obesity and other MetS components. Finally, it has recently been demonstrated that NAFLD is associated with an increased risk of all-cause death and predicts future CVD events independently of other prognostic factors, including MetS components. Overall, therefore, the evidence from these recent studies strongly emphasizes the importance of assessing the global CVD risk in patients with NAFLD. Moreover, these novel findings suggest a more complex picture and raise the possibility that NAFLD, as a component of the MetS, might not only be a marker but also an early mediator of CVD. 相似文献
109.
The objective of this study is to determine whether a normal fetal morphology ultrasound scan in women older than 35 years reduces the risk of aneuploidy. We reviewed the results of amniocentesis and second trimester sonogram in all women older than 35 years from 1991 to 1995. None had prior screening. We excluded fetuses with structural anomalies. We determined the sensitivity and specificity of minor markers in detecting Down syndrome and also determined the reduction in risk of a normal sonogram. Among the 2060 women older than 35 years giving birth during the study period, 16 (0.78%) delivered an infant with Down syndrome. Of the 16 fetuses, two had no prenatal testing or ultrasound, two had invasive testing but no second trimester sonogram, five had a normal sonogram and seven had one or more sonographic markers of Down syndrome. At least 17% of women older than 35 years did not participate in prenatal testing or ultrasound. Ultrasound detected Down syndrome with a sensitivity of 59% (95% confidence interval: 45–72%), a false‐positive rate of 10.6% (9.4–11.8%) and a positive predictor value of 1 in 9. The likelihood of having normal karyotype if the sonogram was normal was 0.46 (0.31–0.61). In women older than 35 years, a normal second trimester sonogram reduces the risk of Down syndrome by more than 50%. At least 17% of women older than 35 years do not participate in prenatal testing or ultrasound. 相似文献
110.